BioInvent International AB (BINV) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.93x

BioInvent International AB (BINV) has a Cash Flow Reinvestment Rate of 1.93x as of June 2025, reinvesting Skr128.56 Million (capex Skr1.38 Million plus investments Skr-127.18 Million) from operating cash flow of Skr66.78 Million. Check earnings quality score of BioInvent International AB to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.93x

(Capex + Investments) / Operating CF

Total Reinvested

Skr128.56 Million

Capex + Investments

Operating Cash Flow

Skr66.78 Million

SEK

Capital Expenditures

Skr1.38 Million

SEK

BioInvent International AB Cash Flow Reinvestment Rate (2007–2008)

Historical reinvestment intensity for BioInvent International AB across 2 annual periods. Explore BINV cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for BioInvent International AB (2007–2008)

Year-by-year capital reinvestment analysis for BioInvent International AB. For live market cap and broader valuation context, see BioInvent International AB stock valuation.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2008	0.31x	Skr13.64 Million	Skr43.73 Million	Skr13.64 Million	▲ +0.8%
2007	0.31x	Skr3.91 Million	Skr12.63 Million	Skr3.91 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow